Cathie Wood Just Bought $22 Million of CoreWeave Across 2 ARK Funds

Chris Arnold • 6 minute read
Reviewed by: Chris Arnold
Last updated Nov 22, 2026

@putilich from Getty Images via Canva, @alengo from Getty Images Signature via Canva

Key Takeaways

  • Cathie Wood’s ARK Invest bought 549,659 shares of CoreWeave on Friday in two of its ETFs, ARKK and ARKW. That’s about $22 million at Friday’s close.
  • CoreWeave trades at 0.9x forward sales, its lowest point in the past year and far below its 3.4x average, while analysts expect its revenue to reach $27.1 billion in 2027.
  • Oracle, another AI cloud, faces the same test: whether demand for AI computing pays back the cost of building it.
  • On price, the numbers back the buy, and the yield on CoreWeave’s next contract-backed loan is the figure to watch.

Cathie Wood just added to one of AI’s most beaten-up stocks. ARK Invest’s daily trade email shows it bought 549,659 shares of CoreWeave (CRWV) on Friday, when the stock was 71% below its 52-week high.

CoreWeave isn’t the only AI cloud investors are doubting. One of its rivals faces the same question about who will fill its new capacity. Oracle (ORCL), which rose with CoreWeave’s last jump, is building its own AI cloud around contracts with OpenAI.

A small add in two funds

ARK split the buy between two ETFs: 432,596 shares went into the ARK Innovation ETF (ARKK) and 117,063 into the ARK Next Generation Internet ETF (ARKW). The new shares are 0.12% of ARKK and 0.13% of ARKW. At Friday’s $39.51 close, the 549,659 shares come to about $22 million. That’s the share count times the close, since the email doesn’t say what ARK paid.

CoreWeave was already a meaningful holding. ARK’s 13F for the quarter ended Sept. 30, filed Nov. 13, showed 4.21 million shares worth $367 million. That was 2.1% of its 13F stocks and its 15th-largest position. It was also 58% more shares than ARK held three months earlier. The filing doesn’t show what ARK did between Sept. 30 and Friday, and CoreWeave’s share price fell 55% from its quarter-end level to Friday’s close.

TIKR tracks 41 analysts on CoreWeave. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on CoreWeave, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See CoreWeave’s Analyst Ratings

At 0.9x sales, the price looks too low

Analysts expect CoreWeave’s sales to keep climbing fast. Revenue was $5.13 billion in 2025, and the forecasts are $13.1 billion this year, $27.1 billion in 2027 and $45.1 billion in 2028:

Bar chart from TIKR of CoreWeave's revenue, actual and consensus estimates, $ billions, fiscal 2025-2028.
CoreWeave (CRWV): revenue, actual and consensus estimates, $ billions, fiscal 2025-2028 (TIKR)

Profit forecasts have gone the other way. Analysts have cut their normalized 2028 EPS estimate to $1.33 from $4.39 a year ago, even as they raised their revenue numbers. Depreciation, interest and new shares are eating much of the growth.

Investors now pay 0.9x forward sales for CoreWeave. That’s the lowest point of the past year, against a 3.4x average and a 6.0x peak in May:

Line chart from TIKR of CoreWeave's forward (NTM) price/sales, last year.
CoreWeave (CRWV): forward (NTM) price/sales, last year (TIKR)

Analysts’ targets have fallen far less than the stock. The consensus target has slipped to $115 from $131 a year ago:

Line chart from TIKR of CoreWeave's analysts' consensus (mean) price target, $ per share, last year.
CoreWeave (CRWV): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

Over the same year, the stock fell to $39.51 from $69.21. That puts the average target 191% above Friday’s close, although the lowest target, $39, is right around where the stock trades now. Revenue estimates keep rising and the multiple is at its low for the year. So on price, the numbers side with ARK.

Nebius and Oracle face the same test

The same doubt hangs over Nebius (NBIS). Its third-quarter results, filed Nov. 12, show revenue jumped to $980.8 million from $146.1 million a year earlier, and operating costs of $930.4 million came in just under that. TIKR has argued that a gigawatt of compute can’t simply be sold as inference, and that’s a problem for both CoreWeave and Nebius. So Nebius has to answer the same question CoreWeave does: who rents all that capacity a few years from now?

Oracle shares the customer at the center of CoreWeave’s story. CoreWeave has $22.4 billion in contracts with OpenAI. On Friday, Oracle said its own infrastructure contract with OpenAI is fully funded after a final capital raise earlier this month. Oracle’s backlog was $664 billion at Aug. 31. But its free cash flow was negative $5 billion in its fiscal first quarter, and it sold $20 billion of stock that quarter.

CoreWeave is still lining up its money. Bloomberg reported on Nov. 18 that it’s in talks to raise at least $4 billion through an investment-grade loan backed by a contract with Meta. Oracle’s report on Dec. 10 will give an early read on the same OpenAI demand CoreWeave is counting on.

Cheap, with a funding catch

The risk is money. Analysts expect CoreWeave’s free cash flow to stay negative every year through 2030. Nvidia, a CoreWeave shareholder, has also signaled it will be choosier about which companies it helps finance.

The way I see it, the numbers back ARK at this price. At 0.9x forward sales, investors are pricing CoreWeave as if little of its revenue ever turns into profit, even as analysts keep raising their revenue forecasts.

The next loan is the test. CoreWeave said on Nov. 12 that it expects its next contract-backed loan to yield 7% to 7.5%. A deal priced in that range would show lenders still want in, and anything well above it would give the bears the stronger case. ARK’s next 13F, due in mid-February, will show whether it kept adding.

So what is CoreWeave stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what CoreWeave could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value CoreWeave for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required